MedPath

PREGABALIN

These highlights do not include all the information needed to use PREGABALIN ORAL SOLUTION safely and effectively. See full prescribing information for PREGABALIN ORAL SOLUTION. PREGABALIN Oral Solution, CV Initial U.S. Approval: 2004

Approved
Approval ID

d92c94e5-e542-4177-afa8-fa00ba17634c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 21, 2022

Manufacturers
FDA

Patrin Pharma, Inc.

DUNS: 806841677

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PREGABALIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code39328-090
Application NumberANDA212604
Product Classification
M
Marketing Category
C73584
G
Generic Name
PREGABALIN
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2022
FDA Product Classification

INGREDIENTS (8)

PREGABALINActive
Quantity: 20 mg in 1 mL
Code: 55JG375S6M
Classification: ACTIB
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RN
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6F
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
STRAWBERRYInactive
Code: 4J2TY8Y81V
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PREGABALIN - FDA Drug Approval Details